New parameters for assessing glucose metabolism in elderly patients with diabetes mellitus

1.           Teo E, Hassan N, Tam W, Koh S. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis. Diabetologia 2022; 65(4): 604–619.

2.           Seidu S, Kunutsor SK, Ajjan RA, et al. Efficacy and safety of continuous glucose monitoring and intermittently scanned continuous glucose monitoring in patients with type 2 diabetes: a systematic review and meta-analysis of interventional evidence. Diabetes Care 2024; 47(1): 169–179.

3.           Bergenstal RM, Beck RW, Close Kl, et al. Glucose Management Indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Diabetes Care 2018; 41(11): 2275–2280.

4.           Beck RW, Connor CG, Mullen DM, et al. The fallacy of average: How using HbA_1c alone to assess glycemic control can be misleading. Diabetes Care 2017; 40(8): 994–999.

5.           Toschi E, Slyne C, Sifre K, O’Donnell R, et al. The relationship between CGM-derived metrics, A_1C, and risk of hypoglycemia in older adults with type 1 diabetes. Diabetes Care 2020; 43(10): 2349–2354.

6.           Fang M, Wang D, Rooney MR, et al. Performance of the Glucose Management Indicator (GMI) in type 2 diabetes. Clin Chem 2023; 69(4): 422–428.

7.           Selvin E, Wang D, Rooney MR, et al. The associations of mean glucose and time in range from continuous glucose monitoring with HbA_1c in adults with type 2 diabetes. Diabetes Technol Ther 2023; 25(1): 86–90.

8.           Ling J, Ng JKCC, Lau ESH, et al. Continuous glucose monitoring metrics in the assessment of glycemia in moderate-to-advanced CKD in diabetes. Kidney Int Rep 2022; 7(6): 1354–1363.

9.           Oriot P, Viry C, Vandelaer A, et al. Discordance between glycated hemoglobin A_1c and the glucose management indicator in people with diabetes and chronic kidney disease. J Diabetes Sci Technol 2023; 17(6): 1553–1562.

10.        Perlman JE, Gooley TA, McNulty B, et al. HbA_1c and glucose management indicator discordance: a real-world analysis. Diabetes Technol Ther 2021; 23(4): 253–
258.

11.        Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 2019; 42(8): 1593–1603.

12.        Nováková M, Kotvová V, Tománková L, et al. Okamžité monitorování glukózy u seniorů hospitalizovaných na Geriatrické interní klinice 2. LF UK a FN Motol. Kazuistiky v diabetologii 2024; 22(2). V tisku.